ReviewFrontiers in neurology2026
Data-driven vestibular fMRI in PPPD and residual dizziness after BPPV: a narrative methodological review of AI-based phenotyping and longitudinal modeling.
Review in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Neuroimaging studies of vertigo and chronic dizziness have identified abnormalities across vestibular, visual, somatosensory, and cognitive-emotional networks, but conventional group-level analyses are limited in capturing individual heterogeneity and longitudinal change. This narrative methodological review integrates current evidence and proposes a framework combining functional magnetic resonance imaging (fMRI), artificial intelligence (AI), and advanced statistical modeling, anchored in two priority research scenarios: PPPD phenotyping and longitudinal characterization of residual dizziness after BPPV repositioning. AI, particularly unsupervised learning, may help identify candidate network subtypes from high-dimensional fMRI features, whereas mixed-effects, nonlinear, and latent trajectory models can evaluate their longitudinal stability, clinical relevance, and temporal evolution. Together, these approaches form a complementary pattern-discovery-longitudinal-validation framework. Current evidence, however, remains limited by small samples, single-center designs, technical heterogeneity, and scarce external validation. Accordingly, candidate PPPD subgroups and proposed recovery trajectories after BPPV repositioning should be regarded as hypothesis-generating rather than established fMRI phenotypes. The framework is therefore intended primarily as a research methodology for mechanistic investigation, candidate biomarker discovery, and prospective validation rather than as a clinically deployable decision tool. Future progress will require larger multicenter cohorts, harmonized acquisition and preprocessing, rigorous control of confounding and multiple testing, independent validation, and demonstration of incremental value beyond established clinical assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.